315 related articles for article (PubMed ID: 3978640)
1. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
Fodstad O; Aamdal S; Pihl A; Boyd MR
Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors.
Aamdal S; Fodstad O; Kaalhus O; Pihl A
Int J Cancer; 1986 Apr; 37(4):579-87. PubMed ID: 3957463
[TBL] [Abstract][Full Text] [Related]
3. Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
Kjønniksen I; Breistøl K; Fodstad O
Cancer Res; 1992 Mar; 52(5):1347-51. PubMed ID: 1737396
[TBL] [Abstract][Full Text] [Related]
4. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
5. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.
Dexter DL; Hesson DP; Ardecky RJ; Rao GV; Tippett DL; Dusak BA; Paull KD; Plowman J; DeLarco BM; Narayanan VL
Cancer Res; 1985 Nov; 45(11 Pt 1):5563-8. PubMed ID: 4053030
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic response of human tumor xenografts in athymic mice to doxorubicin.
Giuliani FC; Zirvi KA; Kaplan NO
Cancer Res; 1981 Jan; 41(1):325-35. PubMed ID: 7448772
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
8. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM
Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
[TBL] [Abstract][Full Text] [Related]
9. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
10. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice.
Howell SB; Jenkins RS; Streifel J
Cancer Res; 1979 Oct; 39(10):3875-80. PubMed ID: 476623
[TBL] [Abstract][Full Text] [Related]
11. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
Kubota T; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1439-47. PubMed ID: 1854214
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
Geiger T; Müller M; Monia BP; Fabbro D
Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
[TBL] [Abstract][Full Text] [Related]
14. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.
Fiebig HH; Berger DP; Köpping K; Ottenheijm HC; Zylicz Z
J Cancer Res Clin Oncol; 1990; 116(6):550-6. PubMed ID: 2254373
[TBL] [Abstract][Full Text] [Related]
16. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
Aamdal S; Fodstad O; Pihl A
Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of five xenografted human cancers and two murine cancers by the tripeptide tyroservatide.
Fu Z; Lu R; Jia J; Zhao L; Ma R; Lv JQ; Li XL; Chen LJ; Zhang HL; Wang L; Yao Z
Anticancer Drugs; 2007 Apr; 18(4):467-70. PubMed ID: 17351399
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
19. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors.
Plowman J; Harrison SD; Dykes DJ; Paull KD; Narayanan VL; Tobol HK; Martin J; Griswold DP
Cancer Res; 1989 Apr; 49(8):1909-15. PubMed ID: 2702634
[TBL] [Abstract][Full Text] [Related]
20. Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle.
Aamdal S; Fodstad O; Kaalhus O; Pihl A
J Natl Cancer Inst; 1984 Sep; 73(3):743-52. PubMed ID: 6590919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
